Pharmagy ApS: Financial statements 2024
CVR: 41488514
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Pharmagy ApS (CVR 41488514) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 3,225,687 and a net result of DKK 1,080,195 compared with DKK 807,787 the year before. That is an increase of 15.6% compared with the year before. Equity in the 2024 report amounted to DKK 2,787,027. The solvency ratio was 77.6%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 3,225,687
- Profit/Loss
- DKK 1,080,195
- Equity
- DKK 2,787,027
- Total Assets
- DKK 3,593,749
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 3.2M | 1.1M | 2.8M | 2 |
| 2023 | - | 2.8M | 808K | 1.9M | 2 |
| 2022 | - | 2.7M | 731K | 1.3M | 2 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Pharmagy ApS has published its annual report for 2023. Gross profit came to DKK 2,791,349, and the net result was DKK 807,787.
About Pharmagy ApS
Pharmagy ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2020. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Kirsten Bjerrum and Lars Bøndergaard. The company is owned by LKSynergy ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 3,097,834 and a net result of DKK 966,279 compared with DKK 1,080,195 the year before. Equity in the 2025 report amounted to DKK 3,553,305.